The EDGE program was established to support the development of functional genomic tools and techniques for genome manipulation in model organisms.
Living DNA and its partners are aiming to create a detailed genetic map of the world based on people's DNA.
The partners will test samples from an NSABP biobank on Nanostring's platform and with standard IHC to look for newer biomarkers of cancer immune evasion.
HER3 mRNA expression analysis can predict colorectal cancer patients with wild-type RAS tumors who will respond to panitumumab, US and UK researchers reported.
Alterations affecting the antigen presentation-related gene B2M appeared to be over-represented in melanomas with checkpoint blockade non-response or resistance.
Pillar will use its stem loop inhibition-mediated amplification technology to develop diagnostics that run on Illumina's MiSeqDx instrument.
The partners will work together to study the genomics of cannabis for medical and nutraceutical applications.
In February, the USPTO's Patent Trial and Appeal Board stopped UC's bid for IP underpinning the most lucrative applications of genome editing.
The new institute, co-located with the China National GeneBank, will focus on synthetic biology technologies and applications.
The multiplexed assay is the second available on the Panther Fusion system and the FDA is reviewing a third, the Panther Fusion AdV/hMPV/RV assay.
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
At the Cleveland Clinic Medical Innovation Summit, experts discussed the promise and challenges of genomic and health data, and strategies for taming it.
Using MRSA isolates from England, researchers uncovered hospital-specific, community-specific, and overlapping transmission clusters.
University of Chicago researchers combined epidemiological and viral gene evolution data to refine influenza modeling.
The Liu lab found a way to make edits without causing double-strand DNA breaks while the Zhang lab created an RNA editor that doesn't permanently alter the genome.
The test is designed to detect and differentiate herpes simplex virus types 1 and 2, Treponema pallidum, and varicella-zoster virus.
In the African American arm of a new GWAS, a risk variant in the SEMA3A gene was associated with both alcohol dependence disorder and major depressive disorder.
Clinical testing revenues inched up less than 1 percent, while pharma services revenues rose 38 percent, the company said.
The firm reported organic revenue growth of 5 percent and a particularly strong quarter for its analytical instruments sales.
The firm recognized $714.0 million in revenues due to growth in both its sequencing and microarray portfolios.
Using genomic data from large cancer cell line collections, investigators identified versions of spliced genes that spell better or worse drug response.
The American Dental Association wants insurers and test manufacturers to show genetic testing is scientifically valid before they're used to determine coverage eligibility.
The International Commission on Missing Persons and Qiagen have launched a next-generation sequencing workflow for missing persons DNA identification.
The NIH has awarded $169 million this year to support 110 new projects in the Brain Research through Advancing Innovative Neurotechnologies Initiative.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.